Pliant Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +915.2% | +79.0% | +148.2% | -25.1% | +58.5% | +46.1% | -22.5% | -43.3% | |
| – | +1,211.5% | +81.3% | +159.8% | -28.0% | +62.5% | +48.5% | -28.3% | -45.8% | |
| – | +1,333.8% | +40.8% | -40.7% | +1.5% | -34.8% | +87.7% | +12.6% | -36.2% | |
| – | +1,333.8% | +68.6% | +169.4% | -27.6% | +65.1% | +49.2% | -28.0% | -46.3% | |
| – | +100.0% | +1,377.0% | +26.8% | -73.7% | +27.5% | -4.7% | -23.2% | -64.2% | |
| – | – | – | – | – | +0.0% | – | – | – | |
| – | +130.8% | -4.2% | +5.9% | +153.1% | -59.0% | – | – | – | |
| – | +2,014.5% | +77.3% | -89.6% | +77.7% | +68.2% | +3.5% | +140.7% | -52.6% | |
| – | +59.5% | +60.7% | +41.9% | +45.1% | +42.1% | +19.3% | +16.5% | -50.7% | |
| – | – | – | – | – | +31.5% | -46.4% | -58.9% | +167.0% | |
| – | +61.6% | -51.5% | +61.8% | +46.9% | -46.8% | +186.8% | +31.5% | -91.9% | |
| – | – | – | – | – | – | +1.3% | +200.5% | – | |
| – | -126.4% | – | – | -29.7% | +57.4% | +51.1% | -35.8% | -40.4% | |
| – | – | – | – | – | – | – | – | – | |
| – | +1,954.8% | +115.3% | +0.0% | +0.8% | +17.2% | +39.8% | +3.1% | +1.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.